Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients

Details for Australian Patent Application No. 2005249492 (hide)

Owner The Regents of the University of Colorado

Inventors Garcia, Marileila Varella; Franklin, Wilbur A.; Bunn, Paul A Jr.; Cappuzzo, Federico; Hirsch, Fred R.

Agent Allens Arthur Robinson

Pub. Number AU-B-2005249492

PCT Pub. Number WO2005/117553

Priority 60/677,852 03.05.05 US; 60/575,789 27.05.04 US

Filing date 26 May 2005

Wipo publication date 15 December 2005

Acceptance publication date 22 September 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/117553 Priority application(s): WO2005/117553

22 September 2011 Application Accepted

  Published as AU-B-2005249492

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249493-Diarylalkanes as potent inhibitors of binuclear enzymes

2005249490-Antibody drug conjugates and methods